These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 16123807)

  • 21. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
    Engel ME; Datta PK; Moses HL
    J Cell Biochem Suppl; 1998; 30-31():111-22. PubMed ID: 9893262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of Smad signaling in hematopoiesis.
    Larsson J; Karlsson S
    Oncogene; 2005 Aug; 24(37):5676-92. PubMed ID: 16123801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal transduction and the Ets family of transcription factors.
    Yordy JS; Muise-Helmericks RC
    Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest.
    Nicolás FJ; Hill CS
    Oncogene; 2003 Jun; 22(24):3698-711. PubMed ID: 12802277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas.
    Flanders KC; Kim ES; Roberts AB
    Dev Dyn; 2001 Feb; 220(2):141-54. PubMed ID: 11169847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can't get no SMADisfaction: Smad proteins as positive and negative regulators of TGF-beta family signals.
    Christian JL; Nakayama T
    Bioessays; 1999 May; 21(5):382-90. PubMed ID: 10376010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP.
    Dennler S; Pendaries V; Tacheau C; Costas MA; Mauviel A; Verrecchia F
    Oncogene; 2005 Mar; 24(11):1936-45. PubMed ID: 15688032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transforming growth factor-beta signaling and cancer].
    Miyazono K
    Hum Cell; 2000 Sep; 13(3):97-101. PubMed ID: 11197777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation.
    Verrecchia F; Tacheau C; Schorpp-Kistner M; Angel P; Mauviel A
    Oncogene; 2001 Apr; 20(18):2205-11. PubMed ID: 11402315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-beta signaling by Smad proteins.
    Miyazono K; ten Dijke P; Heldin CH
    Adv Immunol; 2000; 75():115-57. PubMed ID: 10879283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smads and chromatin modulation.
    van Grunsven LA; Verstappen G; Huylebroeck D; Verschueren K
    Cytokine Growth Factor Rev; 2005; 16(4-5):495-512. PubMed ID: 15979924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell type-dependent control of NF-Y activity by TGF-beta.
    Alabert C; Rogers L; Kahn L; Niellez S; Fafet P; Cerulis S; Blanchard JM; Hipskind RA; Vignais ML
    Oncogene; 2006 Jun; 25(24):3387-96. PubMed ID: 16434965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles.
    Javelaud D; Mauviel A
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1161-5. PubMed ID: 15109563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.
    Li JH; Huang XR; Zhu HJ; Oldfield M; Cooper M; Truong LD; Johnson RJ; Lan HY
    FASEB J; 2004 Jan; 18(1):176-8. PubMed ID: 12709399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta signaling, Smads, and tumor suppressors.
    Padgett RW; Das P; Krishna S
    Bioessays; 1998 May; 20(5):382-90. PubMed ID: 9670811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling.
    Mix KS; Coon CI; Rosen ED; Suh N; Sporn MB; Brinckerhoff CE
    Mol Pharmacol; 2004 Feb; 65(2):309-18. PubMed ID: 14742672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells.
    Bolkenius U; Hahn D; Gressner AM; Breitkopf K; Dooley S; Wickert L
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1264-70. PubMed ID: 15555563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.
    Cui Q; Lim SK; Zhao B; Hoffmann FM
    Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.